IRON Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $729K | Sell |
2,896
-188
| -6% | -$40.4K | 0.3% | 64 |
|
|
2026
Q1 | $671K | Sell |
3,084
-253
| -8% | -$56.1K | 0.29% | 63 |
|
|
2025
Q4 | $762K | Buy |
3,337
+209
| +7% | +$47.6K | 0.35% | 52 |
|
|
2025
Q3 | $724K | Sell |
3,128
-57
| -2% | -$11.6K | 0.35% | 59 |
|
|
2025
Q2 | $591K | Buy |
3,185
+674
| +27% | +$125K | 0.31% | 58 |
|
|
2025
Q1 | $526K | Sell |
2,511
-3,900
| -61% | -$758K | 0.3% | 56 |
|
|
2024
Q4 | $1.14M | Buy |
6,411
+142
| +2% | +$26.1K | 0.64% | 28 |
|
|
2024
Q3 | $1.24M | Buy |
6,269
+3,669
| +141% | +$685K | 0.67% | 30 |
|
|
2024
Q2 | $446K | Buy |
2,600
+80
| +3% | +$13.3K | 0.25% | 64 |
|
|
2024
Q1 | $459K | Buy |
2,520
+11
| +0.4% | +$1.9K | 0.26% | 63 |
|
|
2023
Q4 | $389K | Buy |
2,509
+12
| +0.5% | +$1.75K | 0.22% | 68 |
|
|
2023
Q3 | $372K | Sell |
2,497
-243
| -9% | -$35.7K | 0.22% | 67 |
|
|
2023
Q2 | $369K | Sell |
2,740
-166
| -6% | -$24.3K | 0.2% | 62 |
|
|
2023
Q1 | $463K | Buy |
2,906
+15
| +0.5% | +$2.29K | 0.25% | 56 |
|
|
2022
Q4 | $467K | Sell |
2,891
-222
| -7% | -$34K | 0.27% | 57 |
|
|
2022
Q3 | $418K | Buy |
3,113
+19
| +0.6% | +$2.73K | 0.23% | 63 |
|
|
2022
Q2 | $474K | Sell |
3,094
-414
| -12% | -$63.3K | 0.25% | 57 |
|
|
2022
Q1 | $569K | Sell |
3,508
-4,289
| -55% | -$623K | 0.26% | 57 |
|
|
2021
Q4 | $1.06M | Buy |
7,797
+181
| +2% | +$21.4K | 0.47% | 32 |
|
|
2021
Q3 | $822K | Buy |
7,616
+1,146
| +18% | +$131K | 0.39% | 35 |
|
|
2021
Q2 | $729K | Sell |
6,470
-745
| -10% | -$83.9K | 0.34% | 40 |
|
|
2021
Q1 | $781K | Buy |
7,215
+2,043
| +40% | +$219K | 0.41% | 31 |
|
|
2020
Q4 | $554K | Sell |
5,172
-906
| -15% | -$87.1K | 0.28% | 34 |
|
|
2020
Q3 | $532K | Buy |
6,078
+707
| +13% | +$66.6K | 0.29% | 37 |
|
|
2020
Q2 | $527K | Buy |
5,371
+541
| +11% | +$47.6K | 0.27% | 43 |
|
|
2020
Q1 | $368K | Buy |
4,830
+151
| +3% | +$12.9K | 0.23% | 64 |
|
|
2019
Q4 | $414K | Buy |
4,679
+199
| +4% | +$16.5K | 0.2% | 74 |
|
|
2019
Q3 | $339K | Buy |
4,480
+470
| +12% | +$32.2K | 0.25% | 72 |
|
|
2019
Q2 | $323K | Buy |
4,010
+124
| +3% | +$9.75K | 0.3% | 69 |
|
|
2019
Q1 | $313K | Buy |
3,886
+185
| +5% | +$15.1K | 0.2% | 66 |
|
|
2018
Q4 | $341K | Sell |
3,701
-10
| -0.3% | -$879 | 0.27% | 55 |
|
|
2018
Q3 | $351K | Buy |
3,711
+148
| +4% | +$14K | 0.24% | 63 |
|
|
2018
Q2 | $330K | Buy |
3,563
+32
| +0.9% | +$3.13K | 0.18% | 73 |
|
|
2018
Q1 | $334K | Buy |
3,531
+4
| +0.1% | +$439 | 0.21% | 70 |
|
|
2017
Q4 | $341K | Buy |
3,527
+220
| +7% | +$20.7K | 0.24% | 59 |
|
|
2017
Q3 | $294K | Buy |
3,307
+6
| +0.2% | +$457 | 0.22% | 60 |
|
|
2017
Q2 | $239K | Buy |
3,301
+6
| +0.2% | +$403 | 0.21% | 70 |
|
|
2017
Q1 | $215K | Buy |
3,295
+7
| +0.2% | +$440 | 0.15% | 75 |
|
|
2016
Q4 | $206K | Buy |
3,288
+6
| +0.2% | +$366 | 0.14% | 69 |
|
|
2016
Q3 | $207K | Buy |
3,282
+5
| +0.2% | +$324 | 0.25% | 65 |
|
|
2016
Q2 | $203K | Buy |
+3,277
| New | +$200K | 0.26% | 62 |
|
Other funds holding ABBV
ECSS
ATO
IRON Financial's ABBV Position: Q2 2026 in Review
IRON Financial reduced its AbbVie (ABBV) stake by 6.1% in Q2 2026, selling an estimated $40.4K and leaving 2,896 shares worth $729K. The position accounts for 0.3% of the portfolio, ranked #64.
IRON Financial first reported a position in ABBV in Q2 2016 and has held it in 41 quarters since. The position peaked at $1.24M in Q3 2024. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- IRON Financial held 2,896 shares of AbbVie worth $729K as of Q2 2026.
- IRON Financial sold 188 AbbVie shares in Q2 2026, an estimated $40.4K.
- AbbVie made up 0.3% of IRON Financial's portfolio in Q2 2026, its #64 holding.
- IRON Financial first reported a position in AbbVie in Q2 2016 and has held it in 41 quarters since.
- IRON Financial's AbbVie position peaked at $1.24M in Q3 2024.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on IRON Financial's 13F filing for Q2 2026, filed 22 Jul 2026.